These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6775326)

  • 1. Incorporation of 4.5-3-H-leucine into the limbic system of ICR mice as a long-term effect of haloperidol application.
    Hackenberg P
    Psychopharmacology (Berl); 1980; 70(1):105-8. PubMed ID: 6775326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of Fos protein in the limbic regions of the rat following haloperidol decanoate.
    Sun YJ; Suzuki M; Kurachi T; Murata M; Kurachi M
    Brain Res; 1998 Apr; 791(1-2):125-36. PubMed ID: 9593855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of haloperidol-induced increase in rat striatal or mesolimbic 3,4-dihydroxyphenylacetic acid and homovanillic acid by pretreatment with chronic methamphetamine.
    Toru M; Mataga N; Takashima M; Nishikawa T
    Psychopharmacology (Berl); 1981; 74(4):316-20. PubMed ID: 6794073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in the pattern of brain-derived neurotrophic factor immunoreactivity in the rat brain after acute and subchronic haloperidol treatment.
    Dawson NM; Hamid EH; Egan MF; Meredith GE
    Synapse; 2001 Jan; 39(1):70-81. PubMed ID: 11071712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diminished catalepsy and dopamine metabolism distinguish aripiprazole from haloperidol or risperidone.
    Nakai S; Hirose T; Uwahodo Y; Imaoka T; Okazaki H; Miwa T; Nakai M; Yamada S; Dunn B; Burris KD; Molinoff PB; Tottori K; Altar CA; Kikuchi T
    Eur J Pharmacol; 2003 Jul; 472(1-2):89-97. PubMed ID: 12860477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of Fos protein by antipsychotic drugs in rat brain following kainic acid-induced limbic-cortical neuronal loss.
    Roe DL; Bardgett ME; Csernansky CA; Csernansky JG
    Psychopharmacology (Berl); 1998 Jul; 138(2):151-8. PubMed ID: 9718284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Influence of haloperidol on the 3H-leucine incorporation in incretory organs of the mouse (author's transl)].
    Lange E; Hackenberg P
    Zentralbl Allg Pathol; 1978; 122(5):496-501. PubMed ID: 364880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotoninergic modulation of mesolimbic and frontal cortical dopamine neurons.
    Waldmeier PC
    Experientia; 1980 Sep; 36(9):1092-4. PubMed ID: 6448165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different effects of chronic administration of haloperidol and pimozide on dopamine metabolism in the rat brain.
    Karolewicz B; Antkiewicz-Michaluk L; Michaluk J; Vetulani J
    Eur J Pharmacol; 1996 Oct; 313(3):181-6. PubMed ID: 8911913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosing time-dependent tolerance of catalepsy by repetitive administration of haloperidol in mice.
    Viyoch J; Ohdo S; Yukawa E; Higuchi S
    J Pharmacol Exp Ther; 2001 Sep; 298(3):964-9. PubMed ID: 11504791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effect of haloperidol on release of neurotensin in extrapyramidal and limbic systems.
    Huang W; Hanson GR
    Eur J Pharmacol; 1997 Jul; 332(1):15-21. PubMed ID: 9298921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of dopamine synthesis in mesolimbic dopamine neurons by immobilization stress in the rat.
    Watanabe H
    Neuropharmacology; 1984 Nov; 23(11):1335-8. PubMed ID: 6441893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of haloperidol decanoate on the dopaminergic system in the rat brain].
    Kashihara K; Fujiwara Y; Harada T; Ogawa T; Sato M; Otsuki S
    Yakubutsu Seishin Kodo; 1986 Sep; 6(3):353-8. PubMed ID: 3811625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased mesolimbic dopamine binding following chronic haloperidol treatment.
    Kamer RS; Turi AR; Solomon PR; Kaplan LJ
    Psychopharmacology (Berl); 1981; 72(3):261-3. PubMed ID: 6784143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in the time course of haloperidol-induced up-regulation of rat striatal and mesolimbic dopamine receptors.
    Prosser ES; Csernansky JG; Hollister LE
    Life Sci; 1988; 43(8):715-20. PubMed ID: 2901023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The nucleus interstitialis striae terminalis and the nucleus amygdaloideus medialis: prime targets for androgen in the rat forebrain.
    Sheridan PJ
    Endocrinology; 1979 Jan; 104(1):130-6. PubMed ID: 446340
    [No Abstract]   [Full Text] [Related]  

  • 17. Zac1 is up-regulated in neural cells of the limbic system of mouse brain following seizures that provoke strong cell activation.
    Valente T; Domínguez MI; Bellmann A; Journot L; Ferrer I; Auladell C
    Neuroscience; 2004; 128(2):323-36. PubMed ID: 15350644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haloperidol-induced changes in the regional cerebral pharmacokinetics of apomorphine.
    Melzacka M; Wiszniowska G; Daniel W; Vetulani J
    Pol J Pharmacol Pharm; 1979; 31(4):387-91. PubMed ID: 523341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term influence of d-amphetamine on mesolimbic brain-stimulation reward: comparison to chronic haloperidol and naloxone effects.
    Borowski TB; Kokkinidis L
    Pharmacol Biochem Behav; 1992 Sep; 43(1):1-15. PubMed ID: 1409792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in the time course of dopaminergic supersensitivity following chronic administration of haloperidol, molindone, or sulpiride.
    Prosser ES; Pruthi R; Csernansky JG
    Psychopharmacology (Berl); 1989; 99(1):109-16. PubMed ID: 2506596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.